ANI Pharmaceuticals, Inc.
ANIP
$63.26
$1.863.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.64% | -20.61% | 52.78% | 251.63% | 358.49% |
| Total Receivables | 36.80% | 9.80% | -3.95% | -1.31% | -2.03% |
| Inventory | 23.01% | 38.89% | 20.25% | 9.82% | 5.54% |
| Prepaid Expenses | 2.16% | 64.68% | 70.24% | 135.99% | 107.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -97.09% | -22.88% | -74.27% | -97.49% | -52.41% |
| Total Current Assets | 1.51% | 4.84% | 20.93% | 48.20% | 50.99% |
|
|
|||||
| Total Current Assets | 1.51% | 4.84% | 20.93% | 48.20% | 50.99% |
| Net Property, Plant & Equipment | 27.52% | 28.32% | 16.38% | 12.13% | 3.11% |
| Long-term Investments | 112.57% | 114.12% | 0.00% | 0.00% | 0.00% |
| Goodwill | 112.57% | 114.12% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 159.24% | 159.21% | -20.50% | -17.90% | -16.94% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.27% | -16.51% | 7.98% | 12.24% | 15.04% |
| Total Assets | 41.94% | 44.66% | 7.15% | 19.51% | 18.99% |
|
|
|||||
| Total Accounts Payable | 24.46% | 78.68% | 70.78% | 51.22% | 25.18% |
| Total Accrued Expenses | 56.93% | 92.25% | 44.00% | 18.41% | 61.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,218.94% | 741.41% | 0.00% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | -8.09% | -31.48% | -36.64% | -21.45% | 50.03% |
| Total Other Current Liabilities | -8.09% | -31.48% | -36.64% | -21.45% | 50.03% |
| Total Current Liabilities | 33.13% | 41.37% | 13.93% | 8.79% | 46.30% |
|
|
|||||
| Total Current Liabilities | 33.13% | 41.37% | 13.93% | 8.79% | 46.30% |
| Long-Term Debt | 115.90% | 116.89% | -0.30% | -0.30% | -0.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 32.04% | -1.10% | 320.55% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 154.24% | 292.91% | -7.79% | -15.82% | -52.86% |
| Total Liabilities | 91.39% | 96.82% | 3.59% | 2.81% | 6.00% |
|
|
|||||
| Common Stock & APIC | 1.08% | 0.87% | 7.47% | 28.22% | 27.28% |
| Retained Earnings | -25.14% | -10.78% | 28.08% | 35.24% | 17.63% |
| Treasury Stock & Other | -1,182.35% | -463.37% | -357.68% | -475.24% | -117.30% |
| Total Common Equity | -6.72% | -5.56% | 11.26% | 43.65% | 37.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -6.72% | -5.56% | 11.26% | 43.65% | 37.95% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.35% | -5.26% | 10.62% | 40.45% | 35.17% |
|
|
|||||
